Your browser doesn't support javascript.
loading
Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
Jaskowski, Troy D; Nandakumar, Vijayalakshmi; Novis, Camille L; Palmer, Michael; Tebo, Anne E.
Affiliation
  • Jaskowski TD; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
  • Nandakumar V; Department of Pathology, University of Utah Health, Salt Lake City, UT, United States; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
  • Novis CL; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
  • Palmer M; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States.
  • Tebo AE; Department of Pathology, University of Utah Health, Salt Lake City, UT, United States; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States. Electronic address: Tebo.Anne@mayo.edu.
Clin Chim Acta ; 540: 117219, 2023 Feb 01.
Article in En | MEDLINE | ID: mdl-36610465
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Liver Cirrhosis, Biliary Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Clin Chim Acta Year: 2023 Document type: Article Affiliation country: United States Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Liver Cirrhosis, Biliary Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Clin Chim Acta Year: 2023 Document type: Article Affiliation country: United States Country of publication: Netherlands